ECTS Information Guide

Main Page

Information on the Institution

General Description of the Institution Address of Namık Kemal University Academic Calendar Academic Authorities Recognition of Prior Learning Recognition of Study Abroad List of Programmes Offered at TNKÜ General Admission Requirements General Registration Procedures ECTS Credit Allocation Arrangements for Academic Guidance

Degrees and Programmes

Doctorate(Third Cycle) Master's Degree(Second Cycle) Bachelor's Degree(First Cycle) Associate(Short Cycle)

General Information For Students

About Trakya and Tekirdağ Cost of Living Accommodation Meals Medical Facilities Facilities for Students with Special Needs Insurance Financial Support for Students Student Affairs Office Learning Facilities International Programmes Practical Information for Exchange Students Language Courses Internship Sports and Leisure Facilities Student Clubs Useful Phone Numbers

Diploma Supplement

National Qualifications

Veterinary Pharmacology and Toxicology (MA)(Thesis) Master Degree With a Thesis Program

Academic Unit Presenting the Program

Veterinary Pharmacology and Toxicology (MA)(Thesis)

Program Director

Head of Department Prof. Dr. Nurullah ÖZDEMİR Institute Director Prof. Dr. Selami GÜRKAN Deputy Institute Director Assoc. Dr. Birol TOPÇU Deputy Institute Director Assoc. Dr. Serhat ÖRÜN

Program Type

Master Degree With a Thesis Program

Level of Degree Earned

Master's Degree

Degree Earned

After graduation, you will receive a Master's Degree with Thesis in Veterinary Pharmacology and Toxicology.

Education Type

Tam zamanlı.

Registration Acceptance Conditions

In order to apply to the Master's Program in Veterinary Pharmacology and Toxicology with Thesis 1) candidates must have graduated from Veterinary, Medicine, Dentistry, Pharmacy Faculties; Chemistry Department of Science / Science-Literature Faculties; Chemistry Department of Engineering Faculties; Nursing Department of Health Sciences Faculties, must have at least 55 standard points in the numerical score type from ALES, which is centrally conducted by ÖSYM, or must be successful in internationally recognized exams whose success base points are determined by the Senate by accepting equivalence instead of ALES result 2) Success grade in admission to graduate programs is calculated by adding 20% of the undergraduate graduation weighted grade point average, 50% of the standard score obtained from ALES and 30% of the score obtained as a result of the interview conducted by the jury established by the institute board of directors for each department. Students are accepted as many students as the quota announced by ranking from the highest score to the lowest.

Recognition of Prior Learning

A successful student who has completed at least one semester in another department of another institute within the relevant university or institute of high technology or in the graduate program of another higher education institution can apply for the quota of transfer announced in the relevant department. Horizontal transfer; with the approval of the head of the relevant department and the decision of the board of directors of the institute.

Degree Requirements and Rules

to take a minimum of 7 courses with a minimum of 21 local credits.
to succeed in all the courses with a letter grade of at least CC/S
to prepare and defend a master's dissertation
to have a Cumulative Grade Point Average of at least 2.00/4.00 with a minimum of 120 ECTS credits.

Program Profile

Veterinary Pharmacology and Toxicology Master's Program with Thesis started education in 2019-2020 Academic Year Fall Semester with 2 students. Education, training and research activities in the program are carried out with 2 associate professors and 2 doctoral faculty members. The language of instruction is Turkish. The program includes compulsory courses and elective courses related to the field of Veterinary Pharmacology and Toxicology. In the 1st and 2nd semester, compulsory and elective courses related to the field; In the 3rd and 4th semester, thesis work related to the field is carried out.

Occupational Profiles of Graduates

Those who successfully complete the Veterinary Pharmacology and Toxicology Master's Degree with Thesis program can work as lecturers in public and private universities. They are also employed in “expert” positions in different institutions.

Access To Upper Degree

Candidates who have successfully completed their master's degree can study in doctoral programs, provided that they get a valid grade from the ALES exam and have sufficient knowledge of English language.

Exams, Assessment and Grading

In order to be considered successful, the success grade must be at least 65 points in the master's program.

Graduation Requirements

Teaching Methods

Teaching and learning methods and strategies are selected to enhance students' skills such as self-study, lifelong learning, observation, teaching others, presentation, critical thinking, teamwork, and effective use of information technology.

In addition, attention is paid to ensure that the teaching style supports students with different abilities.

Program Outcomes

1-Ability to approach problems in the field, synthesize and design possible solutions and evaluate the effects of solutions on organizational structures and society
2-Ability to learn and use drugs affecting the immune system
3-Ability to learn and use information about nutrition pharmacology
4-Ability to learn and use plant and metal poisoning
5-Ability to learn and use environmental toxicology
6-Ability to learn and use dermatological drugs
7-Ability of interdisciplinary teamwork
8-Ability to acquire and use general concepts in pharmacology, effects of the drug on living organisms and environment and interactions
9-Ability to learn and use homeopathy and homeopathic substances
10-Ability to learn and use information about hormonal system pharmacology
11-Ability to learn and use interaction of drugs
12-Ability to learn and use information about drug forms and prescription information
13-Ability to learn and use information about residue and public health
14-Ability to learn and use blood and drugs that affect blood-forming structures
15-Ability to learn and use cardiovascular pharmacology
16-Ability to learn and use chemotherapeutics
17-Ability to learn and use central nervous system drugs
18-Ability to learn information about mycotoxins and use analysis methods
19-Ability to learn and use autonomic nervous system drugs
20-Ability to design and conclude and report an original research process independently
21-Ability to learn and use analysis methods of pesticides
22-Ability to learn and use drugs affecting liquid-electrolyte and acid-base balance
23-Ability to learn and use digestive system drugs
24-Ability to learn and use respiratory system pharmacology
25-To learn and use general concepts in toxicology, the effects of poisons on living organisms and environment and interactions

Curriculum

Course
Veterinary Pharmacology and Toxicology (MA)(Thesis)
2024-2025 Fall Semester

Course Code	Course Name	Browse	T	A	ECTS
FTYL101	Pharmacology Introduction		3	0	5
LÜ SBE 09	Scientific Research Methods, Research and Publication Ethics		1	2	5
LÜ SBE 04	Special Topics		8	0	10
FTYL118	Toxicology Introduction		2	2	5
Elective	2024 - 2025 Güz Yarıyılı Veterinerlik Farmakoloji ve Toksikoloji Tezli Yüksek Lisans Seçmeli Dersleri()				25
FT 127	Amtiprotozoal Drugs		3	0	5
FTYL104	Analysis Methods of Pesticides		2	2	5
FT 123	Antibacterial Drugs		3	0	5
FT 126	Antifungal Drugs		3	0	5
FT 124	Antiparasitic Drugs		3	0	5
FT 125	Antiviral Drugs		3	0	5
FTYL108	Autonomic Nervous System Drugs		3	0	5
LÜ SBE 03	Biostatistics		3	0	5
FTYL106	Blood and Drugs Affecting Blood-Shaping Structures		3	0	5
FTYL113	Cardiovascular Pharmacology		3	0	5
FTYL102	Central Nervous System Drugs		3	0	5
FTYL111	Dermatological Drugs		3	0	5
FTYL112	Digestive System Drugs		3	0	5
FTYL107	Drug Forms and Prescription Information		2	2	5
FTYL110	Drugs Affecting Liquid-Electrolyte and Acid-Base Balance		3	0	5
FTYL119	Drugs Affecting the Immune System		3	0	5
FTYL109	Environmental Toxicology		2	0	5
FTYL117	Homeopathy and Homeopathic Substances		3	0	5
FTYL114	Hormonal System Pharmacology		3	0	5
FTYL105	Interaction of drugs		3	0	5
FT 130	Medicinal Aromatic Plants		3	0	5
FTYL121	Mycotoxins and Analysis Methods		3	0	5
FTYL116	Nutrition Pharmacology		3	0	5
FT 131	Pharmacogenomics		3	0	5
FT 132	Pharmacoproteomics		3	0	5
FTYL120	Plant and Metal Poisoning		3	0	5
FTYL122	Residue and Public Health		3	0	5
FTYL115	Respiratory System Pharmacology		3	0	5
FT 128	Tumor Chemotherapy		3	0	5
FT 129	Veterinary Apitherapy		3	0	5
Total ECTS:					50
2024-2025 Spring Semester

Course Code	Course Name	Browse	T	A	ECTS
FTYL101	Pharmacology Introduction		3	0	5
LÜ SBE 09	Scientific Research Methods, Research and Publication Ethics		1	2	5
LÜ SBE 05	Seminar		0	2	5
LÜ SBE 04	Special Topics		8	0	10
FTYL118	Toxicology Introduction		2	2	5
Elective	2024-2025 BAHAR YARIYILI VETERİNERLİK FARMAKOLOJİ VE TOKSİKOLOJİ TEZLİ YÜKSEK LİSANS PROGRAMI SEÇMELİ DERSLER()				25
FT 127	Amtiprotozoal Drugs		3	0	5
FTYL104	Analysis Methods of Pesticides		2	2	5
FT 123	Antibacterial Drugs		3	0	5
FT 126	Antifungal Drugs		3	0	5
FT 124	Antiparasitic Drugs		3	0	5
FT 125	Antiviral Drugs		3	0	5
FTYL108	Autonomic Nervous System Drugs		3	0	5
LÜ SBE 03	Biostatistics		3	0	5
FTYL106	Blood and Drugs Affecting Blood-Shaping Structures		3	0	5
FTYL113	Cardiovascular Pharmacology		3	0	5
FTYL102	Central Nervous System Drugs		3	0	5
FTYL111	Dermatological Drugs		3	0	5
FTYL112	Digestive System Drugs		3	0	5
FTYL107	Drug Forms and Prescription Information		2	2	5
FTYL110	Drugs Affecting Liquid-Electrolyte and Acid-Base Balance		3	0	5
FTYL119	Drugs Affecting the Immune System		3	0	5
FTYL109	Environmental Toxicology		2	0	5
FTYL117	Homeopathy and Homeopathic Substances		3	0	5
FTYL114	Hormonal System Pharmacology		3	0	5
FTYL105	Interaction of drugs		3	0	5
FT 130	Medicinal Aromatic Plants		3	0	5
FTYL121	Mycotoxins and Analysis Methods		3	0	5
FTYL116	Nutrition Pharmacology		3	0	5
FT 131	Pharmacogenomics		3	0	5
FT 132	Pharmacoproteomics		3	0	5
FTYL120	Plant and Metal Poisoning		3	0	5
FTYL122	Residue and Public Health		3	0	5
FTYL115	Respiratory System Pharmacology		3	0	5
FT 128	Tumor Chemotherapy		3	0	5
FT 129	Veterinary Apitherapy		3	0	5
Total ECTS:					55
Total ECTS(Year):					105
Thesis
2024-2025 Fall Semester

Course Code	Course Name	Browse	T	A	ECTS
LÜ SBE 04	Special Topics		8	0	10
SBE TEZ 01	Thesis Proposal		1	0	5
SBE TEZ 02	Thesis Work		1	0	15
SBE TEZ 03	Thesis Writing		1	0	5
Total ECTS:					35
2024-2025 Spring Semester

Course Code	Course Name	Browse	T	A	ECTS
LÜ SBE 04	Special Topics		8	0	10
SBE TEZ 01	Thesis Proposal		1	0	5
SBE TEZ 02	Thesis Work		1	0	15
SBE TEZ 03	Thesis Writing		1	0	5
Total ECTS:					35
Total ECTS(Year):					70

Matrix of Course - Program Outcomes

FTYL101 Pharmacology Introduction
#
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1
	3	2	2	2	1	2	3	4	2	2	4	4	3	2	2	2	2	1	2	3	1	2	2	2	1

LÜ SBE 09 Scientific Research Methods, Research and Publication Ethics
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	1	1	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL118 Toxicology Introduction
#
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5

FT 127 Amtiprotozoal Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL104 Analysis Methods of Pesticides
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1

FT 123 Antibacterial Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 126 Antifungal Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 124 Antiparasitic Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 125 Antiviral Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL108 Autonomic Nervous System Drugs
#
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1

LÜ SBE 03 Biostatistics
#
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL106 Blood and Drugs Affecting Blood-Shaping Structures
#
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1

FTYL113 Cardiovascular Pharmacology
#
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1

FTYL102 Central Nervous System Drugs
#
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4

FTYL111 Dermatological Drugs
#
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL112 Digestive System Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	5	1	1
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0

FTYL107 Drug Forms and Prescription Information
#
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1

FTYL110 Drugs Affecting Liquid-Electrolyte and Acid-Base Balance
#
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2

FTYL119 Drugs Affecting the Immune System
#
	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL109 Environmental Toxicology
#
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4

FTYL117 Homeopathy and Homeopathic Substances
#
	2	2	2	2	1	2	3	1	5	2	2	2	1	2	2	2	2	1	2	3	1	1	2	2	2
	1	2	2	0	1	2	3	1	5	0	2	2	1	2	2	2	2	1	2	3	1	1	2	2	2
	1	2	2	0	1	2	3	1	5	0	2	2	1	2	2	2	2	1	2	3	1	1	2	2	2

FTYL114 Hormonal System Pharmacology
#
	2	1	1	1	1	1	2	1	1	5	2	2	1	1	1	1	1	1	1	3	1	1	1	1	2
	2	1	1	1	1	1	2	1	1	5	2	2	1	1	1	1	1	1	1	3	1	1	1	1	1
	2	1	1	1	1	1	2	1	1	5	2	2	1	1	1	1	1	1	1	3	1	1	1	1	1
	2	1	1	1	1	1	2	1	1	5	2	2	1	1	1	1	1	1	1	3	1	1	1	1	1
	2	1	1	1	1	1	2	1	1	5	2	2	1	1	1	1	1	1	1	3	1	1	1	1	1

FTYL105 Interaction of drugs
#
	4	1	1	1	3	1	4	5	1	1	5	2	1	1	1	1	1	1	1	1	1	1	1	1	2
	4	1	1	1	3	1	4	5	1	1	5	2	1	1	1	1	1	1	1	1	1	1	1	1	2
	4	1	1	1	3	1	4	5	1	1	5	2	1	1	1	1	1	1	1	1	1	1	1	1	2
	4	1	1	1	3	1	4	5	1	1	5	2	1	1	1	1	1	1	1	1	1	1	1	1	2

FT 130 Medicinal Aromatic Plants
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL121 Mycotoxins and Analysis Methods
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1

FTYL116 Nutrition Pharmacology
#
	2	1	5	1	1	1	1	2	2	2	1	1	2	1	2	2	2	1	1	2	1	2	1	2	1
	2	1	5	1	1	1	1	2	2	2	1	1	2	1	2	2	2	1	1	2	1	2	1	2	1
	2	1	5	1	1	1	1	2	2	2	1	1	2	1	2	2	2	1	1	2	1	2	1	2	1
	2	1	5	1	1	1	1	2	2	2	1	1	2	1	2	2	2	1	1	2	1	2	1	2	1
	2	1	5	1	1	1	1	2	2	2	1	1	2	1	2	2	2	1	1	2	1	2	1	2	1

FT 131 Pharmacogenomics
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FT 132 Pharmacoproteomics
#
	5	1	1	1	1	1	4	1	1	1	1	5	1	1	1	5	1	1	1	1	1	1	1	1	5
	5	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL120 Plant and Metal Poisoning
#
	4	3	3	5	4	1	3	1	3	2	2	1	3	1	2	1	2	1	1	3	1	1	2	2	3

FTYL122 Residue and Public Health
#
	2	1	1	1	1	1	3	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1
	2	1	1	1	1	1	3	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1
	2	1	1	1	1	1	3	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1

FTYL115 Respiratory System Pharmacology
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	5	1
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0

FT 128 Tumor Chemotherapy
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 129 Veterinary Apitherapy
#
	2	1	2	1	1	2	1	1	1	2	1	2	1	2	2	2	1	1	1	1	1	1	1	1	1

FTYL101 Pharmacology Introduction
#
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1
	5	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1

LÜ SBE 09 Scientific Research Methods, Research and Publication Ethics
#
	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0
	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0
	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0
	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0
	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0

LÜ SBE 05 Seminar
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL118 Toxicology Introduction
#
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5

FT 127 Amtiprotozoal Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL104 Analysis Methods of Pesticides
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1

FT 123 Antibacterial Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 126 Antifungal Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 124 Antiparasitic Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 125 Antiviral Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL108 Autonomic Nervous System Drugs
#
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0

LÜ SBE 03 Biostatistics
#
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL106 Blood and Drugs Affecting Blood-Shaping Structures
#
	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0

FTYL113 Cardiovascular Pharmacology
#
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1
	2	1	1	1	1	1	2	1	1	1	2	2	1	1	4	1	1	1	1	1	1	2	1	1	1

FTYL102 Central Nervous System Drugs
#
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4
	3	5	4	4	5	3	4	4	4	5	4	3	5	4	5	4	3	3	4	4	3	4	5	4	4

FTYL111 Dermatological Drugs
#
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	5	5	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL112 Digestive System Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	5	1	1
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0

FTYL107 Drug Forms and Prescription Information
#
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1
	1	2	2	1	1	2	1	2	2	2	2	4	3	2	2	2	2	1	2	1	1	2	2	2	1

FTYL110 Drugs Affecting Liquid-Electrolyte and Acid-Base Balance
#
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2
	2	2	2	1	1	1	2	2	1	2	3	2	1	2	3	2	2	1	2	1	1	4	2	2	2

FTYL119 Drugs Affecting the Immune System
#
	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL109 Environmental Toxicology
#
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4
	3	1	1	3	1	1	3	1	1	1	2	1	3	1	1	1	1	1	1	2	3	1	1	1	4

FTYL117 Homeopathy and Homeopathic Substances
#
	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL114 Hormonal System Pharmacology
#
	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL105 Interaction of drugs
#
	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 130 Medicinal Aromatic Plants
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL121 Mycotoxins and Analysis Methods
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1
	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	1	1	1	1

FTYL116 Nutrition Pharmacology
#
	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FT 131 Pharmacogenomics
#
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FT 132 Pharmacoproteomics
#
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL120 Plant and Metal Poisoning
#
	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL122 Residue and Public Health
#
	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0

FTYL115 Respiratory System Pharmacology
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	1	1	1	5	1
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0
	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0

FT 128 Tumor Chemotherapy
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 129 Veterinary Apitherapy
#
	2	1	2	1	1	2	1	1	4	2	1	2	1	2	2	2	1	1	1	1	1	1	1	1	1
	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

SBE TEZ 01 Thesis Proposal
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

SBE TEZ 02 Thesis Work
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

SBE TEZ 03 Thesis Writing
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

SBE TEZ 01 Thesis Proposal
#
	5	1	1	1	1	1	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
	5	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

SBE TEZ 02 Thesis Work
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

SBE TEZ 03 Thesis Writing
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL118 Toxicology Introduction
#
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5

FT 127 Amtiprotozoal Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL104 Analysis Methods of Pesticides
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1

FT 123 Antibacterial Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 126 Antifungal Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 124 Antiparasitic Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 125 Antiviral Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL108 Autonomic Nervous System Drugs
#
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1

LÜ SBE 03 Biostatistics
#
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL106 Blood and Drugs Affecting Blood-Shaping Structures
#
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1

FTYL118 Toxicology Introduction
#
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5

FT 127 Amtiprotozoal Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL104 Analysis Methods of Pesticides
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1

FT 123 Antibacterial Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 126 Antifungal Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 124 Antiparasitic Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 125 Antiviral Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL108 Autonomic Nervous System Drugs
#
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1

LÜ SBE 03 Biostatistics
#
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL106 Blood and Drugs Affecting Blood-Shaping Structures
#
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1

FTYL118 Toxicology Introduction
#
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5
	5	1	1	1	5	1	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5

FT 127 Amtiprotozoal Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL104 Analysis Methods of Pesticides
#
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1
	5	1	1	1	1	1	5	1	1	1	1	1	1	1	1	1	1	1	1	5	5	1	1	1	1

FT 123 Antibacterial Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 126 Antifungal Drugs
#
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	4	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 124 Antiparasitic Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FT 125 Antiviral Drugs
#
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
	5	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1

FTYL108 Autonomic Nervous System Drugs
#
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1
	3	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	0	1	1	1	1	1

LÜ SBE 03 Biostatistics
#
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	4	1	1	1	1	1
	3	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

FTYL106 Blood and Drugs Affecting Blood-Shaping Structures
#
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1
	2	2	1	1	1	1	2	1	1	1	2	2	1	5	2	1	1	1	1	1	1	1	1	1	1